Skip to content
Search

Latest Stories

Boots and PDA Union reach agreement in pay talks

Boots and PDA Union reach agreement in pay talks

All eligible pharmacists and pharmacist store managers at Boots will receive a 4% pay increase

Boots and the PDA Union negotiating teams have reached an agreement on this year’s pay claim, following constructive negotiations between both parties. The new pay deal will come into effect from 1 November 2024.

Under the agreement, all eligible pharmacists and pharmacist store managers within the bargaining unit will receive a 4 per cent pay award, recognising their unique role within the community pharmacy sector and the business.


Pharmacists and pharmacist store managers will qualify for the negotiated rates if they are members of the bargaining unit, employed as of 1 November 2024, and not serving a notice period.

However, the pay award will not apply to those who have joined or had a pay increase on or since 1 August 2024, were rated as not performing at EOY 2024, or are a trainee pharmacist.

All qualified pharmacists in the bargaining unit with over 10 years of service at Boots will receive a minimum of £53,000 FTE per annum, while all substantively appointed and performing Boots Pharmacist Store Managers will be paid a minimum of £55,000 FTE per annum.

If any eligible pharmacists or pharmacist store managers remain below this minimum threshold after receiving the 4 per cent pay increase, they will receive an additional adjustment to ensure their salary meets this level. This adjustment will also take effect from 1 November 2024.

Boots has also agreed to increase the honorarium payment for pharmacists supporting trainee pharmacists from £1,000 to £1,500 as a non-consolidated payment.

Eligible pharmacists supporting trainee pharmacists from the 2024/25 cohort onwards will receive the revised payment after the 52-week sign-off is completed, with the amount pro-rated as usual.

Additionally, it has been agreed that the current Short Notice Payments provision and eligibility criteria will continue as last year.

 

 

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less